Health care policy reform and investment activity, combined with advancements in research, development and innovation, are spurring a burst of activity in the life sciences sector. While changes to the broader landscape may be rewriting the global map, the United States continues to outpace the world in biopharmaceutical resources and enterprises, according to JLL’s 2014 Life Sciences C
Register to view the full article
This article is part of our premium content subscription. You need to subscribe to gain access to premium content.
Why Register for NREIonline? It's simple and free, and here is what you get:
• Access to leading real estate industry research.
• Interactive rankings of commercial real estate professionals.
• Submit your own articles, (if approved) which will appear around the site.
Already a member? Log in.